Search Results 381-390 of 16758 for Polymyalgia
This study is designed to explore the experiences of individuals growing up with a genetic diagnosis of SCAs and their families. Participation eligibility.
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
The purpose of this study is to obtain adipose tissue from patients undergoing vascular surgery where EVs can be isolated from the fat and used for research ...
About this study. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate HPN217 as monotherapy to assess the safety, tolerability and pharmacokinetics in patients with relapsed/ refractory ...
The goal of this project is to improve outcomes for patients receiving bone marrow transplant (BMT) and their caregivers by providing a caregiving educational ...
Polymyalgia rheumatica · Post-vasectomy pain syndrome · Precocious puberty · Premature birth · Preterm labor · Prostate cancer · Pulmonary embolism · Pyloric ...
About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...
Funding sources for the Epigenetic Etiology of Human Disease led by Keith Robertson, Ph.D., at Mayo Clinic's campus in Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.